Published in Pharma Investments, Ventures and Law Weekly, December 18th, 2005
The approval was based on the results of the SIDESTEP study, according to the company the largest prospective, randomized, and double-blind clinical trial ever conducted in diabetic patients with moderate-to-severe complicated foot infection. Foot infections commonly occur in patients with diabetes and are known to be difficult to treat.
"Currently there are limited data...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.